Status:
COMPLETED
Age-related Normative Values for the Octopus 900 Perimeter
Lead Sponsor:
University Hospital Tuebingen
Collaborating Sponsors:
Haag-Streit AG
Conditions:
Healthy
Eligibility:
All Genders
11-79 years
Phase:
NA
Brief Summary
The purpose of this study is to determine normal values of the visual field (VF), corrected for age- and reaction time (RT) using the Octopus 900 perimeter and semi-automated kinetic perimetry (SKP).
Eligibility Criteria
Inclusion
- maximum spherical ametropia ± 6 Diopters (D)
- maximum cylindrical ametropia ± 2 D
- distant visual acuity ≥ 1.0 logMAR \[20/20\] for subjects up to 60 years, ≥ 0.8 logMAR \[20/25\] for subjects from 61-70 years, ≥ 0.63 logMAR \[20/30\] for subjects older than 70 years
- isocoria, pupil diameter \> 3mm
- intraocular pressure (air pulse tonometer) ≤ 21mmHg
- normal anterior segments
- ocular fundus: normal appearance of the cup to disc ratio (CDR) ≤ 0.5, interocular difference of CDR \< 0.3
- normal macular region, vessels, and peripheral retinal examination (with undilated pupils).
Exclusion
- amblyopia
- strabismus
- ocular motility disorder
- diseases of the retina
- glaucoma, glaucoma suspect
- macular degeneration
- IOP \> 21 mmHg
- abnormal color vision test (ISPP - Ishihara and Standard Pseudoisochromatic Plates = SPP)
- history or findings of other neuro-ophthalmological disease
- relevant opacities of the central refractive media (cornea, lens, vitreous body)
- use of miotic drugs
- intraocular surgery (except uncomplicated cataract surgery, more than three months previous to testing)
- kerato-refractive surgery (LASIK)
- drugs influencing reaction time
- drugs indicating severe general diseases (anti-diabetic pharmaceuticals and anti-hypertensive medication were allowed for subjects older than 70 years)
- mental diseases (for example psychosis)
- pregnancy, nursing
- acute infections
- heavy smoking (\>10 cigarettes /day)
- alcohol abuse
- diabetic retinopathy
- coronary heart disease
- stroke
- migraine
- Raynaud's syndrome
- suspected lack of compliance
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT01518686
Start Date
June 1 2006
End Date
September 1 2008
Last Update
December 11 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Ophthalmology / Institute for Ophthalmic Research, University of Tübingen
Tübingen, Baden-Wurttemberg, Germany, 72076